Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe, Uncontrolled Asthma

NCT03706079 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

951

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

BIOLOGICAL: Tezepelumab
OTHER: Placebo

Sponsor

AstraZeneca

Collaborators

[object Object]